In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea

Hwa Yum Jong, Ki Kim Chang, Dongeun Yong, Kyungwon Lee, Yunsop Chong, Min Kim Cheol, Mi Kim Jeong, Seonggu Ro, Myung Cho Joong

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The in vitro activities of CG400549, a novel FabI inhibitor, were compared to those of linezolid and commonly used antimicrobials against recent bacterial isolates. CG400549 had an MIC90 of 0.5 μg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin.

Original languageEnglish
Pages (from-to)2591-2593
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume51
Issue number7
DOIs
Publication statusPublished - 2007 Jul 1

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea'. Together they form a unique fingerprint.

  • Cite this